News scPharmaceuticals Inc.

Equities

SCPH

US8106481059

Real-time Estimate Cboe BZX Other stock markets 01:31:17 2024-04-25 pm EDT			5-day change	1st Jan Change
4.305 ^USD	-4.33%		-3.99%	-30.94%

Apr. 24	ScPharmaceuticals Inc. Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of Furoscix Auto-Injector (Furosemide 80Mg/Ml) Injection	CI
Mar. 13	Transcript : ScPharmaceuticals Inc., Q4 2023 Earnings Call, Mar 13, 2024

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ScPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection	Apr. 24	AQ
ScPharmaceuticals Inc. Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of Furoscix Auto-Injector (Furosemide 80Mg/Ml) Injection	Apr. 24	CI
Transcript : ScPharmaceuticals Inc., Q4 2023 Earnings Call, Mar 13, 2024	Mar. 13
ScPharmaceuticals Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 13	CI
ScPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update	Mar. 13	AQ
ScPharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 13	CI
ScPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024	Mar. 06	AQ
ScPharmaceuticals to Participate in Two Upcoming Investor Conferences	Feb. 28	AQ
ScPharmaceuticals Expects Higher Q4 Product Sales	Jan. 04	MT
ScPharmaceuticals Announces Preliminary Unaudited Q4 and Full-Year 2023 Net FUROSCIX® Revenue	Jan. 04	AQ
ScPharmaceuticals Inc. Provides Revenue Guidance for the Full Year 2023	Jan. 04	CI
Transcript : ScPharmaceuticals Inc., Q3 2023 Earnings Call, Nov 08, 2023	Nov. 08
ScPharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08	CI
ScPharmaceuticals Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update	Nov. 08	AQ
ScPharmaceuticals to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023	Nov. 01	AQ
ScPharmaceuticals to Participate in Two Upcoming Investor Conferences	23-10-31	AQ
ScPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	23-10-05	AQ
ScPharmaceuticals Announces Positive Feedback from Two FDA Meetings on Key Long-Term Growth Initiatives	23-09-19	AQ
Scpharmaceuticals Announces Positive Feedback from Two Fda Meetings on Key Long-Term Growth Initiatives	23-09-19	CI
ScPharmaceuticals Inc.(NasdaqGS:SCPH) added to S&P Global BMI Index	23-09-18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News scPharmaceuticals Inc.

Equities

SCPH

US8106481059

Summary

Filters